Skip to content

Microbial Markers for AGI

Investigation on the Microbial Biomarkers of AGI in the Early Stage

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04957888
Enrollment
584
Registered
2021-07-12
Start date
2020-07-01
Completion date
2021-07-01
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Gastrointestinal Injury

Keywords

microbiome, metabolome, biomarker

Brief summary

AGI is very common in ICU and sometimes will trigger the development of gut derived sepsis. Thus, to find out the biomarker in early stage is very important to improve the overall prognosis of critically ill patients. In this project we try to find out the microbial biomarker of AGI through multi-omic technology.

Interventions

OTHERnone intervention

none intervention.

Sponsors

Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

All those critically ill patients with anticipated ICU stay for more than 2 days

Exclusion criteria

Patients will be excluded if they have any of the following situations: patients who have not signed the informed consent; Unable to tolerate intra-abdominal pressure monitoring; pregnant woman; Patients after bladder surgery; Systemic diseases and recent use of related drugs; He had a history of infectious diseases, such as tuberculosis or PPD positive. History of hypertension and poor blood pressure control (SBP / DBP \> = 140mmHg); Patients with severe mental illness; Long term use of traditional Chinese medicine, probiotics, gastric mucosal protective agents, proton pump inhibitors, chemotherapy or immunosuppressive drugs, etc. were not included if the drug was not stopped within one month before admission. \-

Design outcomes

Primary

MeasureTime frameDescription
The AUC value of the combined markers1 yearThe combined diagnostic accuracy of AGI through omic parameters

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026